BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1877 related articles for article (PubMed ID: 11986126)

  • 1. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.
    Alexander GE; Furey ML; Grady CL; Pietrini P; Brady DR; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1997 Feb; 154(2):165-72. PubMed ID: 9016263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study.
    Pietrini P; Furey ML; Alexander GE; Mentis MJ; Dani A; Guazzelli M; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Mar; 156(3):470-3. PubMed ID: 10080567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive deficits and regional brain metabolism in Alzheimer's disease.
    Woo BK; Harwood DG; Melrose RJ; Mandelkern MA; Campa OM; Walston A; Sultzer DL
    Int J Geriatr Psychiatry; 2010 Nov; 25(11):1150-8. PubMed ID: 20069587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
    Hunt A; Schönknecht P; Henze M; Seidl U; Haberkorn U; Schröder J
    Psychiatry Res; 2007 Jul; 155(2):147-54. PubMed ID: 17524628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].
    Xiao SF; Cao QY; Xue HB; Liu YC; Zuo CT; Jiang KD; Zhang MY
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2975-9. PubMed ID: 16324383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients.
    Kim EJ; Cho SS; Jeong Y; Park KC; Kang SJ; Kang E; Kim SE; Lee KH; Na DL
    Brain; 2005 Aug; 128(Pt 8):1790-801. PubMed ID: 15888536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET.
    Pietrini P; Alexander GE; Furey ML; Dani A; Mentis MJ; Horwitz B; Guazzelli M; Shapiro MB; Rapoport SI
    J Nucl Med; 2000 Apr; 41(4):575-83. PubMed ID: 10768555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Cilostazol Administration in Alzheimer's Disease Patients with White Matter Lesions: A Positron-Emission Tomography Study.
    Lee JY; Lee H; Yoo HB; Choi JS; Jung HY; Yoon EJ; Kim H; Jung YH; Lee HY; Kim YK
    Neurotherapeutics; 2019 Apr; 16(2):394-403. PubMed ID: 30761509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of memantine on clinical ratings, fluorodeoxyglucose positron emission tomography measurements, and cerebrospinal fluid assays in patients with moderate to severe Alzheimer dementia: a 24-week, randomized, clinical trial.
    Wang T; Huang Q; Reiman EM; Chen K; Li X; Li G; Lin Z; Li C; Xiao S
    J Clin Psychopharmacol; 2013 Oct; 33(5):636-42. PubMed ID: 23948786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the impact of grape consumption on brain metabolism and cognitive function in patients with mild decline in cognition: A double-blinded placebo controlled pilot study.
    Lee J; Torosyan N; Silverman DH
    Exp Gerontol; 2017 Jan; 87(Pt A):121-128. PubMed ID: 27856335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-center study on Alzheimer's disease using FDG PET: group and individual analyses.
    Yuan X; Shan B; Ma Y; Tian J; Jiang K; Cao Q; Wang R
    J Alzheimers Dis; 2010; 19(3):927-35. PubMed ID: 20157248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
    Matthews DC; Mao X; Dowd K; Tsakanikas D; Jiang CS; Meuser C; Andrews RD; Lukic AS; Lee J; Hampilos N; Shafiian N; Sano M; David Mozley P; Fillit H; McEwen BS; Shungu DC; Pereira AC
    Brain; 2021 Dec; 144(12):3742-3755. PubMed ID: 34145880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
    Herholz K
    Expert Rev Neurother; 2010 Nov; 10(11):1667-73. PubMed ID: 20977325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical abnormalities in Alzheimer's disease.
    Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
    Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 94.